Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study

被引：0
|
作者：
Kapoor, R. [1 ]
Sellebjerg, F. [2 ]
Hartung, H. -P. [3 ]
Arnold, D. L. [4 ]
Freedman, M. S. [5 ]
Jeffery, D. [6 ]
Miller, A. [7 ]
Edwards, K. R. [8 ]
Singh, C. M. [9 ]
Chang, I. [9 ]
Ren, Z. [9 ]
Sangurdekar, D. [9 ]
Zhu, B. [9 ]
Sheikh, S. [9 ]
Mehta, D. [9 ]
Ho, P. -R. [9 ]
Campbell, N. [9 ]
Edwards, M. [9 ]
Fisher, E. [9 ]
Kieseier, B. C. [9 ]
Rudick, R. A. [9 ]
Plavina, T. [9 ]
机构：
[1] UCL Inst Neurol, London, England
[2] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Rigshosp, Copenhagen, Denmark
[3] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany
[4] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[5] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[6] Piedmont HealthCare, Mooresville, NC USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] MS Ctr Northeastern New York, Latham, NY USA
[9] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1740
引用
下载
收藏
页码：988 / 988
页数：1
相关论文
共 50 条
  • [21] Serum neurofilament light as a biomarker in progressive multiple sclerosis
    Kapoor, Raju
    Smith, Kathryn E.
    Allegretta, Mark
    Arnold, Douglas L.
    Carroll, William
    Comabella, Manuel
    Furlan, Roberto
    Harp, Christopher
    Kuhle, Jens
    Leppert, David
    Plavina, Tatiana
    Sellebjerg, Finn
    Sincock, Caroline
    Teunissen, Charlotte E.
    Topalli, Ilir
    von Raison, Florian
    Walker, Elizabeth
    Fox, Robert J.
    NEUROLOGY, 2020, 95 (10) : 436 - 444
  • [22] Association of serum neurofilament light levels and disease progression in patients with relapsing remitting multiple sclerosis treated with natalizumab
    Bridel, C.
    Leurs, C.
    Van Lierop, Z.
    Dekker, I.
    van Kempen, Z.
    Twaalfhoven, H.
    Moraal, B.
    Barkhof, F.
    Uitdehaag, B.
    Killestein, J.
    Teunissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 54 - 55
  • [23] Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
    Engel, Sinah
    Protopapa, Maria
    Steffen, Falk
    Papanastasiou, Vakis
    Nicolaou, Christoforos
    Protopapas, Michalis
    Zipp, Frauke
    Bittner, Stefan
    Luessi, Felix
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [24] Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
    Proschmann, Undine
    Inojosa, Hernan
    Akgun, Katja
    Ziemssen, Tjalf
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [25] Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study
    Cuello, J. P.
    Martinez Gines, M. L.
    Kuhle, J.
    Garcia Dominguez, J. M.
    Lozano Ros, A.
    Romero Delgado, F.
    Higueras, Y.
    Meldana Rivera, A.
    Goicochea Briceno, H.
    Garcia-Tizon Larroca, S.
    De Leon-Luis, J.
    Michalak, Z.
    Barro, C.
    Alvarez Lafuente, R.
    Medina Heras, S.
    Fernandez Velasco, J. I.
    Tejeda-Velarde, A.
    Dominguez-Mozo, M. I.
    Muriel, A.
    de Andres, C.
    Villar, L. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (09) : 1200 - 1204
  • [26] Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study
    Cuello, J. P.
    Martinez Gines, M. L.
    Lozano Ros, A.
    Romero Delgado, F.
    Garcia Dominguez, J. M.
    Higueras, Y.
    Meldana Rivera, A.
    Garcia Tizon, S.
    de Leon-Luis, J.
    Ortega Abad, V.
    Perez Perez, S.
    Dominguez-Mozo, M. I.
    Alvarez Lafuente, R.
    Medina Heras, S.
    Fernandez Velasco, J. I.
    Tejeda-velarde, A.
    Andres, C. de
    Goicochea Briceno, H.
    Kuhle, J.
    Michalak, Z.
    Barro, C.
    Villar Guimerans, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 556 - 556
  • [27] Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
    Fox, Robert J.
    Raska, Paola
    Barro, Christian
    Karafa, Matthew
    Konig, Victoria
    Bermel, Robert A.
    Chase, Marianne
    Coffey, Christopher S.
    Goodman, Andrew D.
    Klawiter, Eric C.
    Naismith, Robert T.
    Kuhle, Jens
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (13) : 2014 - 2022
  • [28] CSF neurofilament light chain levels are markedly reduced by fingolimod in relapsing multiple sclerosis
    Kuhle, J.
    Stites, T.
    Chen, Y.
    Dahlke, F.
    Francis, G.
    Sfikas, N.
    Radue, E. -W.
    Giovannoni, G.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 559 - 560
  • [29] Blood neurofilament light levels are reduced following ocrelizumab treatment in patients with relapsing and primary progressive multiple sclerosis
    Bar-or, A.
    Thanei, G. -A.
    Harp, C.
    Cross, A.
    Hauser, S.
    Jia, X.
    Kuhle, J.
    Leppert, D.
    Model, F.
    Fiore, D.
    Koendgen, H.
    Hendricks, R.
    Fischer, S.
    Manfrini, M.
    Herman, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 197 - 197
  • [30] High-dose intravenous steroid therapy reduces serum neurofilament light chain levels in progressive multiple sclerosis
    Stork, Lidia
    Haupts, Michael
    Niels, Kruse
    Spill-Askeridis, Petra
    Weber, Martin
    Brueck, Wolfgang
    Metz, Imke
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 949 - 949
12345